{"rows":[{"id":5733,"title":"Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement","authors":"Pérez Rosal Sergio R., Faber Sonya C.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100029","pubmed_id":null,"openalex_id":"https://openalex.org/W7169607828","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-19 01:20:13","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100029","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100029","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","doi":"10.1016/j.psyche.2026.100029","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3113,"title":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","authors":"Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100032","pubmed_id":null,"openalex_id":"https://openalex.org/W7171862645","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","substance_tags":"psilocybin","topic_tags":"Cancer Patients","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 11:03:46","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100032","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100032","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100032","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","doi":"10.1016/j.psyche.2026.100032","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5679,"title":"Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.","authors":"Seyfourian P, Marks LC, Claar LD, Nahas Y, Keating M, Koch C, Rembado I","journal":"Journal of neuroscience methods","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jneumeth.2026.110848","pubmed_id":"42401399","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Consciousness,Biomarkers,Aging,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-09 01:20:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42401399","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42401399","source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","doi":"10.1016/j.jneumeth.2026.110848","pmid":"42401399","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":64,"title":"Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression","authors":"Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha","journal":"Journal of Affective Disorders","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jad.2026.122063","pubmed_id":"42248535","openalex_id":"https://openalex.org/W7163510976","source_url":"https://doi.org/10.1016/j.jad.2026.122063","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Treatment-Resistant Depression,Veterans","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42248535","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.jad.2026.122063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42248535","source_url":"https://doi.org/10.1016/j.jad.2026.122063","doi":"10.1016/j.jad.2026.122063","pmid":"42248535","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":302,"title":"Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats","authors":"Ladislavová Lucie, Kútná Viera, Mazochová Kristýna, Šíchová Klára, Danda Hynek, Lhotková Eva, Uttl Libor, Brejtr Vojtěch, Syrová Kateřina, Mazoch Vladimír, Horsley Rachel, Páleníček Tomáš","journal":"Pharmacology Biochemistry and Behavior","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.pbb.2026.174231","pubmed_id":"42379524","openalex_id":"https://openalex.org/W7166640155","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","substance_tags":"psilocin","topic_tags":"Neurogenesis,Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379524","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.pbb.2026.174231","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379524","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","doi":"10.1016/j.pbb.2026.174231","pmid":"42379524","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":120,"title":"Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults","authors":"Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C.","journal":"American Journal of Preventive Medicine","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.amepre.2026.108381","pubmed_id":"42092643","openalex_id":"https://openalex.org/W7160017394","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","substance_tags":"psilocybin","topic_tags":"Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42092643","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.amepre.2026.108381","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42092643","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","doi":"10.1016/j.amepre.2026.108381","pmid":"42092643","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5920,"title":"Characterizing Psychedelic-Evoked Familiarity: A Comparative Study with Autobiographical and Déjà Vu Experiences.","authors":"Lawrence DW, Doss MK, O'Connor AR","journal":"Journal of psychoactive drugs","publication_date":"2026-09-11","publication_year":2026,"doi":"10.1080/02791072.2026.2729618","pubmed_id":"42725633","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42725633/","substance_tags":"psilocybin","topic_tags":"Anxiety,Emotional Processing,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-09-12 01:20:05","last_checked":"2026-09-12 01:20:05","bibtex":null,"source_record_id":"PMID:42725633","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42725633/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42725633","source_url":"https://pubmed.ncbi.nlm.nih.gov/42725633/","doi":"10.1080/02791072.2026.2729618","pmid":"42725633","publication_date":"2026-09-11","importer_version":"2.1.3","text_redistributed":false}},{"id":3684,"title":"TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy","authors":"M.D. Anderson Cancer Center","journal":"ClinicalTrials.gov","publication_date":"2026-09-11","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06200155","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-09-12 01:30:17","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06200155","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06200155","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06200155","source_url":"https://clinicaltrials.gov/study/NCT06200155","doi":"","pmid":"","publication_date":"2026-09-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5922,"title":"Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System","authors":"Krantz, M.; Haigney, M. C.; Southworth, M. R.; Stockbridge, N.; Kao, D. P.","journal":"medRxiv","publication_date":"2026-09-10","publication_year":2026,"doi":"10.64898/2026.09.08.26362577","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.08.26362577","substance_tags":"psilocybin","topic_tags":"Addiction,Review Article,Safety,Adverse Events","study_type":"Review Article","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-12 01:20:56","last_checked":"2026-09-12 01:20:56","bibtex":null,"source_record_id":"DOI:10.64898/2026.09.08.26362577","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.08.26362577","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.08.26362577","source_url":"https://doi.org/10.64898/2026.09.08.26362577","doi":"10.64898/2026.09.08.26362577","pmid":"","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5921,"title":"Psilocybin Restores Spatial Memory but Not Fronto-Hippocampal Synchrony in a Rat Model of Alzheimer's Disease.","authors":"Shamsedin M.","journal":"Neuroscience research","publication_date":"2026-09-10","publication_year":2026,"doi":"10.1016/j.neures.2026.105117","pubmed_id":"42722038","openalex_id":null,"source_url":"https://doi.org/10.1016/j.neures.2026.105117","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Animal Study,Toxicity","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-12 01:20:06","last_checked":"2026-09-12 01:20:30","bibtex":null,"source_record_id":"PMID:42722038","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.neures.2026.105117","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42722038","source_url":"https://doi.org/10.1016/j.neures.2026.105117","doi":"10.1016/j.neures.2026.105117","pmid":"42722038","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5917,"title":"What Is Psilocybin?","authors":"Walter KL.","journal":"JAMA","publication_date":"2026-09-10","publication_year":2026,"doi":"10.1001/jama.2026.18064","pubmed_id":"42721017","openalex_id":"https://openalex.org/W7212188604","source_url":"https://doi.org/10.1001/jama.2026.18064","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-11 01:20:04","last_checked":"2026-09-12 01:20:34","bibtex":null,"source_record_id":"PMID:42721017","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1001/jama.2026.18064","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42721017","source_url":"https://doi.org/10.1001/jama.2026.18064","doi":"10.1001/jama.2026.18064","pmid":"42721017","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5855,"title":"Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.","authors":"Kaadt E, Søkilde RF, Garling HD, Raval NR, Lundgaard L, Just J, Knudsen GM, Elfving B","journal":"European journal of pharmacology","publication_date":"2026-09-10","publication_year":2026,"doi":"10.1016/j.ejphar.2026.179222","pubmed_id":"42580506","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42580506/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Adolescents","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-08-13 01:20:05","last_checked":"2026-09-12 01:20:06","bibtex":null,"source_record_id":"PMID:42580506","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42580506/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42580506","source_url":"https://pubmed.ncbi.nlm.nih.gov/42580506/","doi":"10.1016/j.ejphar.2026.179222","pmid":"42580506","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":1943,"title":"Psilocybin.","authors":"Rosenblat JD, Husain MI.","journal":"JAMA","publication_date":"2026-09-10","publication_year":2026,"doi":"10.1001/jama.2026.11874","pubmed_id":"42720966","openalex_id":"https://openalex.org/W4300552542","source_url":"https://doi.org/10.1001/jama.2026.11874","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-09-12 01:20:34","bibtex":null,"source_record_id":"PMID:42720966","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1001/jama.2026.11874","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42720966","source_url":"https://doi.org/10.1001/jama.2026.11874","doi":"10.1001/jama.2026.11874","pmid":"42720966","publication_date":"2026-09-10","importer_version":"2.1.3","text_redistributed":false}},{"id":5919,"title":"Psilocybin selectively suppresses novelty-induced grooming via 5-HT2B receptors: A microstructure analysis in Wistar rats.","authors":"Seillier A, El Dannan GI, Seillier L.","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2026-09-09","publication_year":2026,"doi":"10.1016/j.pnpbp.2026.111924","pubmed_id":"42716333","openalex_id":null,"source_url":"https://doi.org/10.1016/j.pnpbp.2026.111924","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-11 01:20:04","last_checked":"2026-09-12 01:20:30","bibtex":null,"source_record_id":"PMID:42716333","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.pnpbp.2026.111924","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42716333","source_url":"https://doi.org/10.1016/j.pnpbp.2026.111924","doi":"10.1016/j.pnpbp.2026.111924","pmid":"42716333","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5918,"title":"Psychedelic 4-AcO-DMT attenuated looming-induced freezing behaviors by activating PrL CaMKIIα neurons in mice.","authors":"Xia K, Wang Y, Liu J, Yao Y, Su R, Yan H.","journal":"Molecular psychiatry","publication_date":"2026-09-09","publication_year":2026,"doi":"10.1038/s41380-026-03894-9","pubmed_id":"42716959","openalex_id":null,"source_url":"https://doi.org/10.1038/s41380-026-03894-9","substance_tags":"psilocybin,psilocin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Emotional Processing,Animal Study","study_type":"Animal Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-11 01:20:04","last_checked":"2026-09-12 01:20:30","bibtex":null,"source_record_id":"PMID:42716959","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1038/s41380-026-03894-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42716959","source_url":"https://doi.org/10.1038/s41380-026-03894-9","doi":"10.1038/s41380-026-03894-9","pmid":"42716959","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5916,"title":"A Two-Threshold Model of Psilocybin Response Explains Variability in Psychedelic-Assisted Therapy for Treatment-Resistant Depression","authors":"Castillo-Sánchez JI.","journal":"Research Square","publication_date":"2026-09-09","publication_year":2026,"doi":"10.21203/rs.3.rs-10847377/v1","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.21203/rs.3.rs-10847377/v1","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Pharmacology,Consciousness,Mystical Experience,Randomized Controlled Trial,Treatment-Resistant Depression","study_type":"Randomized Controlled Trial","source_name":"Europe PMC","publication_status":"preprint","date_added":"2026-09-10 01:20:30","last_checked":"2026-09-12 01:20:30","bibtex":null,"source_record_id":"DOI:10.21203/rs.3.rs-10847377/v1","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.21203/rs.3.rs-10847377/v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"DOI:10.21203/rs.3.rs-10847377/v1","source_url":"https://doi.org/10.21203/rs.3.rs-10847377/v1","doi":"10.21203/rs.3.rs-10847377/v1","pmid":"","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5914,"title":"Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care.","authors":"Strandberg L, Fernandes TP, Shoshina II, Santos NA, Saether N.","journal":"Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999)","publication_date":"2026-09-09","publication_year":2026,"doi":"10.47626/1516-4446-2026-5060","pubmed_id":"42715291","openalex_id":null,"source_url":"https://doi.org/10.47626/1516-4446-2026-5060","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-10 01:20:06","last_checked":"2026-09-12 01:20:30","bibtex":null,"source_record_id":"PMID:42715291","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.47626/1516-4446-2026-5060","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42715291","source_url":"https://doi.org/10.47626/1516-4446-2026-5060","doi":"10.47626/1516-4446-2026-5060","pmid":"42715291","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":3479,"title":"A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial","authors":"University of Calgary","journal":"ClinicalTrials.gov","publication_date":"2026-09-09","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06615908","substance_tags":"psilocybin","topic_tags":"Anxiety,PTSD,Headache / Migraine,Emotional Processing,Randomized Controlled Trial,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-09-12 01:30:17","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06615908","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06615908","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06615908","source_url":"https://clinicaltrials.gov/study/NCT06615908","doi":"","pmid":"","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":3452,"title":"A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease","authors":"Jennifer Mitchell","journal":"ClinicalTrials.gov","publication_date":"2026-09-09","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07386730","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Mechanism of Action,Biomarkers,Aging,Wellbeing,Animal Study,Healthy Volunteers,Older Adults,Safety,Inflammation","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-09-12 01:30:17","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07386730","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07386730","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07386730","source_url":"https://clinicaltrials.gov/study/NCT07386730","doi":"","pmid":"","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":3511,"title":"Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence","authors":"University of Calgary","journal":"ClinicalTrials.gov","publication_date":"2026-09-08","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06885996","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Mechanism of Action,Biomarkers,Oxidative Stress,Emotional Processing,Randomized Controlled Trial,Inflammation","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-09-12 01:30:17","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06885996","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06885996","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06885996","source_url":"https://clinicaltrials.gov/study/NCT06885996","doi":"","pmid":"","publication_date":"2026-09-08","importer_version":"2.1.3","text_redistributed":false}}],"total":5017,"page":1,"per_page":20,"pages":251,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}